Dynamic Technology Lab Private Ltd Has $1.15 Million Stock Position in Privia Health Group, Inc. $PRVA

Key Points

• Dynamic Technology Lab Private Ltd increased its position in Privia Health Group by 146.5% in Q1, now holding 51,396 shares valued at approximately $1.15 million.
• Analysts have generally positive outlooks for Privia Health Group, with a current average target price of $28.58 and many firms, including JPMorgan and Citigroup, giving it favorable ratings.
• Privia Health Group reported earnings of $0.02 per share, missing expectations, but its revenue increased by 23.4% year-over-year, reaching $521.15 million.

Dynamic Technology Lab Private Ltd increased its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 146.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 51,396 shares of the company's stock after acquiring an additional 30,546 shares during the period. Dynamic Technology Lab Private Ltd's holdings in Privia Health Group were worth $1,154,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PRVA. CWM LLC grew its position in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Bessemer Group Inc. lifted its holdings in Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after buying an additional 2,178 shares during the period. Russell Investments Group Ltd. lifted its holdings in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after buying an additional 2,567 shares during the period. GAMMA Investing LLC lifted its holdings in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after buying an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock worth $75,000 after buying an additional 3,173 shares during the period. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Performance

Shares of NASDAQ:PRVA traded down $0.12 during midday trading on Friday, reaching $22.79. The company's stock had a trading volume of 519,722 shares, compared to its average volume of 696,910. The firm has a market capitalization of $2.80 billion, a price-to-earnings ratio of 207.20, a PEG ratio of 3.32 and a beta of 0.82. The firm has a 50 day moving average price of $21.11 and a two-hundred day moving average price of $22.53. Privia Health Group, Inc. has a fifty-two week low of $16.47 and a fifty-two week high of $26.09.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business had revenue of $521.15 million during the quarter, compared to analyst estimates of $466.97 million. During the same period in the prior year, the firm earned $0.19 earnings per share. The firm's revenue for the quarter was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

PRVA has been the topic of several recent research reports. Piper Sandler cut their target price on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a report on Monday, August 11th. Barclays lifted their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 27th. Stephens reaffirmed an "overweight" rating and set a $32.00 target price on shares of Privia Health Group in a report on Thursday, September 4th. Evercore ISI cut their target price on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. Finally, Zacks Research raised Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $28.58.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.